Improving FDA's COVID-19 vaccine authorization and approval process: Lessons from hydroxychloroquine

In a new article, researchers propose reforms that the U.S. Food and Drug Administration (FDA) could implement to improve the emergency use authorization process and drug approvals during public health crises, which could increase the FDA's credibility and the public's trust in it.